CEN || Diabetes

Salt targets could reduce cardiovascular disease burden and health expenditures

Posted on: 05/05/2014 - 15:01

MELBOURNE – Reducing salt intake to less than 5 g/day could reduce deaths from cardiovascular disease by 11% and significantly decrease out-of-pocket health expenditures, particularly among...

Field of Interest: Cardiology

Type: News Item

Adding empagliflozin to metformin improved glycemic control in type 2 diabetes

Posted on: 24/04/2014 - 17:10

Empagliflozin was associated with dose-dependent improvements in glycemic control and weight when added to metformin in adults with type 2 diabetes, according to researchers. <link...

Field of Interest: Endocrinology

Type: News Item

LDL particle number advantageous in managing cardiovascular risk

Posted on: 23/04/2014 - 15:05

WASHINGTON – High-risk patients managed to a target LDL particle number rather than to an LDL cholesterol goal had 25% fewer cardiovascular events over 3 years of follow-up. "These new data...

Field of Interest: Cardiology

Type: News Item

Better blood pressure, glycemic control in patients with type 2 diabetes on CPAP for apnea

Posted on: 21/04/2014 - 20:34

Treatment with continuous positive airway pressure leads to significantly better diabetes and blood pressure control at 5 years among diabetics with obstructive sleep apnea, according to results from...

Field of Interest: Endocrinology

Type: News Item

FDA approves GLP-1 receptor agonist albiglutide for type 2 diabetes

Posted on: 15/04/2014 - 21:15

Albiglutide, a once-weekly subcutaneous injection, has been approved by the Food and Drug Administration to improve glycemic control, in conjunction with diet and exercise in type 2...

Field of Interest: Endocrinology

Type: News Item

Newcomer misses noninferiority mark against established GLP-1 receptor agonist

Posted on: 10/04/2014 - 19:20

Once-daily liraglutide slightly outperformed once-weekly albiglutide in a head-to-head trial in adults with poorly controlled type 2 diabetes, researchers reported in the April issue of the Lancet...

Field of Interest: Endocrinology

Type: News Item

FDA panel backs approval of inhaled insulin for type 1 and 2 diabetes

Posted on: 02/04/2014 - 17:40

HYATTSVILLE, MD. – Inhaled insulin will probably become available as a treatment option again, with a Food and Drug Administration advisory panel’s recommendation to approve an orally administered...

Field of Interest: Endocrinology

Type: News Item

Is bariatric surgery the right treatment model for obesity?

Posted on: 25/03/2014 - 21:10

WASHINGTON – Bariatric surgery has the greatest amount of data demonstrating its efficacy in reducing the comorbidities of obesity, as well as providing a long-term solution to the disease itself,...

Field of Interest: Endocrinology

Type: News Item

Adding HbA1c doesn’t improve CVD risk assessment

Posted on: 25/03/2014 - 20:00

Adding hemoglobin A1c level to traditional cardiovascular risk factors doesn’t improve the prediction of incident cardiovascular disease among middle-age and older adults who don’t have...

Field of Interest: Endocrinology

Type: News Item

Nanotherapies make inroads in wound regeneration

Posted on: 21/03/2014 - 22:00

DENVER – Move over, gauze, bandages, and moist wound-healing techniques. Nanomaterials are making significant inroads in wound regeneration. Dr. Adam Friedman, director of dermatologic research at...

Field of Interest: Endocrinology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters